AU3058784A – Analgesic compositions
– Google Patents
AU3058784A – Analgesic compositions
– Google Patents
Analgesic compositions
Info
Publication number
AU3058784A
AU3058784A
AU30587/84A
AU3058784A
AU3058784A
AU 3058784 A
AU3058784 A
AU 3058784A
AU 30587/84 A
AU30587/84 A
AU 30587/84A
AU 3058784 A
AU3058784 A
AU 3058784A
AU 3058784 A
AU3058784 A
AU 3058784A
Authority
AU
Australia
Prior art keywords
analgesic compositions
analgesic
compositions
Prior art date
1983-07-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU30587/84A
Other versions
AU568550B2
(en
Inventor
Brian Lee Buckwalter
Thomas Robert Lahann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1983-07-14
Filing date
1984-07-13
Publication date
1985-01-17
1984-07-13
Application filed by Procter and Gamble Co
filed
Critical
Procter and Gamble Co
1985-01-17
Publication of AU3058784A
publication
Critical
patent/AU3058784A/en
1988-01-07
Application granted
granted
Critical
1988-01-07
Publication of AU568550B2
publication
Critical
patent/AU568550B2/en
2004-07-13
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/16—Amides, e.g. hydroxamic acids
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/04—Centrally acting analgesics, e.g. opioids
AU30587/84A
1983-07-14
1984-07-13
Analgesic compositions
Ceased
AU568550B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US514206
1983-07-14
US06/514,206
US4493848A
(en)
1983-07-14
1983-07-14
Compositions and methods useful for producing analgesia
Publications (2)
Publication Number
Publication Date
AU3058784A
true
AU3058784A
(en)
1985-01-17
AU568550B2
AU568550B2
(en)
1988-01-07
Family
ID=24046228
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU30587/84A
Ceased
AU568550B2
(en)
1983-07-14
1984-07-13
Analgesic compositions
Country Status (15)
Country
Link
US
(1)
US4493848A
(en)
EP
(1)
EP0132113B1
(en)
JP
(1)
JPS6075429A
(en)
AU
(1)
AU568550B2
(en)
CA
(1)
CA1244046A
(en)
DE
(1)
DE3474773D1
(en)
DK
(1)
DK163958C
(en)
GB
(1)
GB2144328B
(en)
HK
(1)
HK87390A
(en)
IE
(1)
IE57565B1
(en)
MY
(1)
MY101934A
(en)
NZ
(1)
NZ208901A
(en)
PH
(1)
PH22794A
(en)
SG
(1)
SG32289G
(en)
ZA
(1)
ZA845391B
(en)
Families Citing this family (65)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4564633A
(en)
*
1983-07-14
1986-01-14
The Procter & Gamble Company
Compositions and methods useful for producing analgesia
US4681897A
(en)
*
1984-01-16
1987-07-21
The Procter & Gamble Company
Pharmaceutical products providing enhanced analgesia
US4573995A
(en)
*
1984-10-09
1986-03-04
Alza Corporation
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4898887A
(en)
*
1984-12-20
1990-02-06
The Procter & Gamble Company
Compounds and compositions having anti-inflammatory and analgesic activity
GB2178031B
(en)
1985-06-10
1989-07-26
Procter & Gamble
Phenylacetic acid amides having anti-inflammatory and analgesic activity
US5013759A
(en)
*
1985-06-10
1991-05-07
The Procter & Gamble Company
Compounds and compositions having anti-inflammatory and analgesic activity
US4689182A
(en)
*
1985-12-20
1987-08-25
Warner-Lambert Company
Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity
US4990533A
(en)
*
1985-12-20
1991-02-05
Warner-Lambert Co.
Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity
WO1989004297A1
(en)
*
1986-08-19
1989-05-18
Warner-Lambert Company
4′-hydroxybenzylamine derivatives having anti-inflammatory and analgesic activity
US4980366A
(en)
*
1986-08-19
1990-12-25
Warner-Lambert Co.
Amide, sulfonamide, urea, carbamate, thiocarbamate, and thiourea derivatives of 4’hydroxybenzylamine having anti-inflammatory and analgesic activity
US5045565A
(en)
*
1987-03-09
1991-09-03
The Procter & Gamble Company
Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
US5099030A
(en)
*
1987-03-09
1992-03-24
The Procter & Gamble Company
Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
US5461075A
(en)
*
1988-06-17
1995-10-24
The Procter & Gamble Company
Use of vanilloids for the prevention of lesions due to herpes simplex infections
US5063060A
(en)
*
1989-12-19
1991-11-05
Cisco Limited Partnership
Compositions and method for treating painful, inflammatory or allergic disorders
US5962477A
(en)
*
1994-04-12
1999-10-05
Adolor Corporation
Screening methods for cytokine inhibitors
US6190691B1
(en)
1994-04-12
2001-02-20
Adolor Corporation
Methods for treating inflammatory conditions
US5589480A
(en)
*
1994-08-17
1996-12-31
Elkhoury; George F.
Topical application of opioid analgesic drugs such as morphine
US5866143A
(en)
*
1995-03-24
1999-02-02
El Khoury And Stein, Ltd.
Topical application of opioid drugs such as morphine for relief of itching and skin disease
US5762963A
(en)
*
1995-06-07
1998-06-09
Emory University
Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5849761A
(en)
1995-09-12
1998-12-15
Regents Of The University Of California
Peripherally active anti-hyperalgesic opiates
US6573282B1
(en)
1995-09-12
2003-06-03
Adolor Corporation
Peripherally active anti-hyperalgesic opiates
US5856537A
(en)
*
1996-06-26
1999-01-05
The Scripps Research Institute
Inhibitors of oleamide hydrolase
US5919473A
(en)
*
1997-05-12
1999-07-06
Elkhoury; George F.
Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
AU7389098A
(en)
1997-05-16
1998-12-08
Brigham And Women’s Hospital
Local anesthetic formulations
GB9713484D0
(en)
*
1997-06-27
1997-09-03
Smithkline Beecham Plc
Neuroprotective vanilloid compounds
US6011022A
(en)
*
1998-03-03
2000-01-04
El Khoury; George F.
Topical application of muscarinic analgesic drugs such as neostigmine
US20030118645A1
(en)
*
1998-04-29
2003-06-26
Pather S. Indiran
Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1
(en)
*
1998-03-27
2003-05-15
Cima Labs Inc.
Sublingual buccal effervescent
US6576250B1
(en)
1998-03-27
2003-06-10
Cima Labs Inc.
Pharmaceutical compositions for rectal and vaginal administration
US6974590B2
(en)
*
1998-03-27
2005-12-13
Cima Labs Inc.
Sublingual buccal effervescent
US6200604B1
(en)
1998-03-27
2001-03-13
Cima Labs Inc.
Sublingual buccal effervescent
US6689399B1
(en)
2000-03-16
2004-02-10
James R. Dickson
Transdermal delivery of an anti-inflammatory composition
WO2002067966A1
(en)
2001-02-22
2002-09-06
Purdue Research Foundation
Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US7192612B2
(en)
*
2001-02-22
2007-03-20
Purdue Research Foundation
Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
JP2005507865A
(en)
*
2001-08-10
2005-03-24
シンタ ファーマシューティカルズ コーポレーション
Cavalactone composition and methods of use
EP1450824A4
(en)
*
2001-11-02
2005-09-28
Elan Corp Plc
Pharmaceutical composition
GB0217056D0
(en)
*
2002-07-23
2002-08-28
Ass Octel
Use
EA012367B1
(en)
2002-09-05
2009-10-30
Ньюроджескс, Инк.
Composition and method for removal capsaicin from bodily surface, a kit therefor and method for treating pain
JP5189242B2
(en)
*
2002-09-23
2013-04-24
アルケルメス ファーマ アイルランド リミテッド
Abuse-resistant pharmaceutical composition
US20050019436A1
(en)
*
2002-12-18
2005-01-27
Algorx
Injectable capsaicin
SI1587506T1
(en)
*
2002-12-18
2009-04-30
Algorx 101 Interchange Plaza S
Administration of capsaicinoids
AU2004230915B2
(en)
*
2003-04-08
2008-08-07
Algorx Pharmaceuticals, Inc.
Preparation and purification of synthetic capsaicin
CA2522028C
(en)
*
2003-04-10
2011-11-01
Neurogesx, Inc.
Methods and compositions for administration of trpv1 agonists
WO2005065319A2
(en)
*
2003-12-31
2005-07-21
Cima Labs Inc.
Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005065317A2
(en)
*
2003-12-31
2005-07-21
Cima Labs Inc.
Effervescent oral fentanyl dosage form
US20070036853A1
(en)
*
2003-12-31
2007-02-15
Cima Labs Inc.
Generally linear effervescent oral fentanyl dosage form and methods of administering
DE602004031771D1
(en)
*
2003-12-31
2011-04-21
Cima Labs Inc
OPERATING FORM OF OPIATS FOR ORAL USE AND METHOD FOR THE ADMINISTRATION OF OXYCODONE
ITMI20041566A1
(en)
*
2004-07-30
2004-10-30
Indena Spa
«TRPV1 AGONISTS, FORMULATIONS THAT CONTAIN THEM AND THEIR USES»
MX2007006253A
(en)
*
2004-11-24
2007-10-18
Anesiva Inc
Capsaicinoid gel formulation and uses thereof.
US20080268092A1
(en)
*
2004-12-01
2008-10-30
Dacanay Rhodel G
Capsaicin Nutritional Supplement
ZA200707492B
(en)
*
2005-02-14
2009-02-25
Neurogesx Inc
Device for delivery of TRPV1 agonists
WO2006105481A1
(en)
*
2005-03-30
2006-10-05
Neurogesx, Inc.
Low-concentration capsaicin patch and methods for treating neuropathic pain
ES2353399T3
(en)
*
2005-04-01
2011-03-01
Neurogesx, Inc.
CAPSAICINOID OILS AND METHODS TO OBTAIN AND USE THEM.
AU2006241176A1
(en)
*
2005-04-25
2006-11-02
Neurogesx, Inc.
TRPV1 agonist compounds and methods for making and using the same
US7943666B2
(en)
2006-07-24
2011-05-17
Trinity Laboratories, Inc.
Esters of capsaicin for treating pain
US7645767B2
(en)
*
2006-08-31
2010-01-12
Trinity Laboratories, Inc.
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
US8987328B2
(en)
*
2008-10-30
2015-03-24
Trinity Laboratories, Inc.
Esters of capsaicinoids as dietary supplements
US8957207B2
(en)
2009-03-24
2015-02-17
Proteus S.A.
Methods for producing phycotoxins
NO2629610T3
(en)
2010-07-27
2018-02-03
EP2455066B1
(en)
*
2010-11-08
2018-10-17
EPITECH GROUP S.p.A.
Pharmacological preparation for topical use containing N-palmitoyl-vanillamide
AU2011336467A1
(en)
2010-12-01
2013-07-04
Spinal Modulation, Inc.
Agent delivery systems for selective neuromodulation
MX2015012879A
(en)
2013-03-15
2016-06-24
Childrens Medical Center
Neosaxitoxin combination formulations for prolonged local anesthesia.
CA3029246A1
(en)
2016-07-19
2018-01-25
Conagen Inc.
Method for the microbial production of specific natural capsaicinoids
WO2018119343A1
(en)
2016-12-22
2018-06-28
Conagen Inc.
Method for the microbial production of 8-methyl nonanoic acid
US11253493B2
(en)
2017-01-23
2022-02-22
Cliff-Cartwright Corporation
Compositions and methods affecting exercise performance
Family Cites Families (14)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DD75368A
(en)
*
DE938014C
(en)
*
1952-11-05
1956-01-19
Beiersdorf & Co A G P
Process for the production of crystallized vanillylamides
DE1166766B
(en)
*
1961-08-04
1964-04-02
Boehringer Sohn Ingelheim
Process for the preparation of new phenylalkylcarboxamides
FR1336388A
(en)
*
1961-08-04
1963-08-30
Boehringer Sohn Ingelheim
Process for the preparation of amides of phenylalkylcarboxylic acids
BE626897A
(en)
*
1962-01-17
NL132935C
(en)
*
1964-12-04
US4238508A
(en)
*
1979-08-17
1980-12-09
The Research Foundation Of State University Of New York
Method for analgesia using 3-hydroxyacetanilide
US4313958A
(en)
*
1980-10-24
1982-02-02
The Procter & Gamble Company
Method of producing analgesia
US4401663A
(en)
*
1981-06-30
1983-08-30
The Procter & Gamble Company
Novel sulfonamide derivatives
US4544668A
(en)
*
1983-07-14
1985-10-01
The Procter & Gamble Company
Compounds and compositions useful for producing analgesia
US4532139A
(en)
*
1983-07-14
1985-07-30
The Procter & Gamble Company
Compounds and compositions useful for producing analgesia
US4544669A
(en)
*
1983-07-14
1985-10-01
The Procter & Gamble Company
Compounds and compositions useful for producing analgesia
JPS6139413A
(en)
*
1984-07-31
1986-02-25
日立電線株式会社
Method of producing slackness suppressed wire
JPS6147752A
(en)
*
1984-08-14
1986-03-08
Fujikura Ltd
Flame-retardant composition and flame-retardant cable using same
1983
1983-07-14
US
US06/514,206
patent/US4493848A/en
not_active
Expired – Lifetime
1984
1984-07-11
GB
GB08417623A
patent/GB2144328B/en
not_active
Expired
1984-07-11
EP
EP84304727A
patent/EP0132113B1/en
not_active
Expired
1984-07-11
DE
DE8484304727T
patent/DE3474773D1/en
not_active
Expired
1984-07-12
CA
CA000458761A
patent/CA1244046A/en
not_active
Expired
1984-07-12
ZA
ZA845391A
patent/ZA845391B/en
unknown
1984-07-13
PH
PH30980A
patent/PH22794A/en
unknown
1984-07-13
DK
DK345684A
patent/DK163958C/en
not_active
IP Right Cessation
1984-07-13
AU
AU30587/84A
patent/AU568550B2/en
not_active
Ceased
1984-07-13
NZ
NZ208901A
patent/NZ208901A/en
unknown
1984-07-13
IE
IE1812/84A
patent/IE57565B1/en
not_active
IP Right Cessation
1984-07-13
JP
JP59145858A
patent/JPS6075429A/en
active
Pending
1987
1987-09-30
MY
MYPI87002601A
patent/MY101934A/en
unknown
1989
1989-05-20
SG
SG322/89A
patent/SG32289G/en
unknown
1990
1990-10-25
HK
HK873/90A
patent/HK87390A/en
unknown
Also Published As
Publication number
Publication date
DK163958B
(en)
1992-04-27
GB2144328B
(en)
1987-01-21
SG32289G
(en)
1989-09-22
ZA845391B
(en)
1985-03-27
IE57565B1
(en)
1992-12-16
IE841812L
(en)
1985-01-14
CA1244046A
(en)
1988-11-01
GB2144328A
(en)
1985-03-06
PH22794A
(en)
1988-12-12
DE3474773D1
(en)
1988-12-01
GB8417623D0
(en)
1984-08-15
EP0132113A1
(en)
1985-01-23
EP0132113B1
(en)
1988-10-26
DK345684D0
(en)
1984-07-13
US4493848A
(en)
1985-01-15
HK87390A
(en)
1990-11-02
DK163958C
(en)
1992-09-21
DK345684A
(en)
1985-01-15
AU568550B2
(en)
1988-01-07
MY101934A
(en)
1992-02-15
JPS6075429A
(en)
1985-04-27
NZ208901A
(en)
1988-03-30
Similar Documents
Publication
Publication Date
Title
AU568550B2
(en)
1988-01-07
Analgesic compositions
AU580117B2
(en)
1989-01-05
Analgesic compositions
DE3477734D1
(en)
1989-05-24
Analgesic compositions
AU579115B2
(en)
1988-11-17
Intumescent composition
AU566271B2
(en)
1987-10-15
Photopolymerizable composition
GB8519256D0
(en)
1985-09-04
Analgesic/anti-inflammatory compositions
AU3503984A
(en)
1985-05-07
Pharmaceutical compositions
AU566653B2
(en)
1987-10-29
Photopolymerizable composition
AU566596B2
(en)
1987-10-22
Bitumenous compositions
AU549070B2
(en)
1986-01-09
Nalbuphine-narcotic analgesic composition
AU544594B2
(en)
1985-06-06
Polyorgansiloxane composition
AU550915B2
(en)
1986-04-10
Epoxy-polymide-rubber composition
AU573248B2
(en)
1988-06-02
Bitumenous compositions
AU550877B2
(en)
1986-04-10
Polyamide-rubber composition
AU566310B2
(en)
1987-10-15
Photopolymerizable composition
AU566308B2
(en)
1987-10-15
Photopolymerizable composition
AU566309B2
(en)
1987-10-15
Photopolymerizable composition
AU563927B2
(en)
1987-07-30
Compositions
AU566272B2
(en)
1987-10-15
Photopolymerizable composition
AU569084B2
(en)
1988-01-21
Photopolymerizable composition
AU2880784A
(en)
1984-12-13
Photopolymerizable composition
AU565526B2
(en)
1987-09-17
Compounds and compositions
AU565135B2
(en)
1987-09-03
Photopolymerizable composition
AU568652B2
(en)
1988-01-07
Photopolymerizable composition
AU566935B2
(en)
1987-11-05
Photopolymerizable composition
None